LANTHANUM CARBONATE
Generic: LANTHANUM CARBONATE
Cipla USA Inc.Manufacturer
ORALRoute
LANTHANUM CARBONATEActive Substance
2022-01-24Original Approval
LANTHANUM CARBONATE is FDA application ANDA206868, sponsored by INVAGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-10-24
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen PFailed stability specifications: Out of specification for hardness test
Class II2025-10-24
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen PFailed stability specifications: Out of specification for hardness test
Top Reported Reactions
1
GENERAL PHYSICAL HEALTH DETERIORATION
271 reports
2
HYPONATRAEMIA
270 reports
3
OFF LABEL USE
269 reports
4
SEPSIS
269 reports
5
NAUSEA
266 reports
6
MULTIPLE ORGAN DYSFUNCTION SYNDROME
264 reports
7
VOMITING
264 reports
8
ABDOMINAL DISTENSION
255 reports
9
STRESS
255 reports
10
ABDOMINAL PAIN
249 reports